FENNEC PHARMACEUTICALS INC. (FENC) › Operating Cash FlowFENNEC PHARMACEUTICALS INC. (FENC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$1.93M2011: -$3.23M2012: -$2.99M2013: -$2.21M2014: -$1.70M2016: -$2.12M2017: -$3.64M2018: -$7.83M2019: -$9.06M2020: -$15.60M2021: -$14.22M2022: -$18.06M2023: -$17.14M2024: $26.98M2025: -$12.47M-$12.47M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$12.47M-146.2%2024$26.98M+257.4%2023-$17.14M+5.1%2022-$18.06M-27.0%2021-$14.22M+8.8%2020-$15.60M-72.1%2019-$9.06M-15.8%2018-$7.83M-114.9%2017-$3.64M-71.4%2016-$2.12M—2014-$1.70M+23.1%2013-$2.21M+26.2%2012-$2.99M+7.2%2011-$3.23M-67.3%2010-$1.93M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share